These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3557264)

  • 1. [Prevention of kinetosis in children. Transdermal therapy with scopolamine].
    Müller M; Besch W; Steilner D
    Fortschr Med; 1987 Feb; 105(4):82, 86-7. PubMed ID: 3557264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action].
    Wang E
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct; 25(5):299-302, 319. PubMed ID: 2076342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z; Shupak A; Gordon CR
    Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
    Gil A; Nachum Z; Tal D; Shupak A
    Clin Neuropharmacol; 2012; 35(1):37-9. PubMed ID: 22139622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy].
    Becker G; Goossens H; Seemann K; Souchon F; Weitz T
    Dtsch Med Wochenschr; 1984 Dec; 109(49):1881-5. PubMed ID: 6499689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delirium after transdermal scopolamine patch in two children.
    Lin CH; Lung HL; Li ST; Lin CY
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E01-2. PubMed ID: 24763767
    [No Abstract]   [Full Text] [Related]  

  • 7. Delirium due to scopolamine patch in a 4-year-old boy.
    Lin YG; Chen PH; Chang FY; Wu LT; Liao KY; Wu TC
    J Formos Med Assoc; 2011 Mar; 110(3):208-11. PubMed ID: 21497284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermally applied scopolamine for continuous prevention of motion sickness. Revival of a 150-year-old method].
    Becker G
    Schweiz Rundsch Med Prax; 1985 Mar; 74(11):271-6. PubMed ID: 3887535
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled-release transdermal drug delivery.
    Kelly HW
    Cutis; 1985 Mar; 35(3):204, 207. PubMed ID: 3920010
    [No Abstract]   [Full Text] [Related]  

  • 10. Anisocoria from scopolamine patches.
    Price BH
    JAMA; 1985 Mar; 253(11):1561. PubMed ID: 3974034
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of simulator sickness in an AH-64 aviator.
    Crowley JS
    Aviat Space Environ Med; 1990 Jun; 61(6):584-5. PubMed ID: 2369402
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.
    Howland J; Rohsenow DJ; Minsky S; Snoberg J; Tagerud S; Hunt SK; Almeida A; Greece J; Allensworth-Davies D
    Int J Occup Environ Health; 2008; 14(4):250-6. PubMed ID: 19043911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Requirement of an "ideal" drug for prevention of space motion sickness].
    Karkishchenko NN
    Kosm Biol Aviakosm Med; 1989; 23(6):33-6. PubMed ID: 2516579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].
    Offenloch K; Zahner G; Dietlein G; Franz I
    Arzneimittelforschung; 1986 Sep; 36(9):1401-6. PubMed ID: 3539128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal scopolamine psychosis.
    Osterholm RK; Camoriano JK
    JAMA; 1982 Jun; 247(22):3081. PubMed ID: 7077797
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of simulator sickness in an AH-64 aviator.
    Kroll JD
    Aviat Space Environ Med; 1989 Dec; 60(12):1202-3. PubMed ID: 2604677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anisocoria following use of the scopoderm disc].
    Hartmann B; Miloh R; Zer I; Kam J
    Harefuah; 1988 Nov; 115(10):276-7. PubMed ID: 3234961
    [No Abstract]   [Full Text] [Related]  

  • 19. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
    Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on the effectiveness of various drugs against airsickness.
    CHINN HI; WALTRIP OH; MASSENGALE HW
    J Aviat Med; 1951 Dec; 22(6):535-9. PubMed ID: 14897805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.